Neuland Laboratories Q1, Q2, Q3, Q4, FY 2017-18, FY 2016-17 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Neuland Laboratories Company Profile :

Neuland Laboratories Limited is an Indian based holding company engaged in the business of manufacturing active pharmaceutical ingredient (API); also provides Custom Manufacturing Solutions to develop and manufacture pharmaceutical ingredients and intermediates, all around the world.

Company’s API products include Alcaftadine, Aripiprazole, Bosentan Monohydrate, Dabigatran Etexilate Mesylate, Deferasirox, Enalapril Maleate, Escitalopram Oxalate, Labetalol Hydrochloride, Posaconazole, Propofol, Ropinirole Hydrochloride, Ticagrelor, Levofloxacin Hemihydrate and Ciprofloxacin Base. It caters to therapeutic categories, including ophthalmic, schizophrenia, vasodilator, fluoroquinolones, ironchelator, chronic obstructive pulmonary disease and cardiovascular. Company also offers peptide synthesis services, including manufacture of complex amino acids, and manufacture of peptide APIs, new chemical entities (NCEs) and impurities.


Neuland Laboratories ResultsBSE Code : 524558
NSE Symbol :  NEULANDLAB
ISIN No. : INE794A01010
Industry : Pharmaceuticals
Face Value : Rs. 10.00


If you are an investor who has shares of Neuland Laboratories or you are an stock market analyst then i am sure you might for Quarterly Results of Neuland Laboratories.

In this article you will find Q1, Q2, Q3, Q4 and FY 2017-18 Results of Neuland Laboratories. That’s not all, you can compare those results with previous year i.e., FY 2016-17 Results of Neuland Laboratories.

Neuland Laboratories Q1 Results 2017-18 :

Neuland Laboratories will announce its Q1 FY 2017-18 Results in August 2017. Will soon update the below mentioned table.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Neuland Laboratories will announce its Q2 FY 2017-18 Results in the month of October 2017.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Neuland Laboratories will announce its Q3 FY 2017-18 Results in the month of January 2018.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Neuland Laboratories will announce its Q4 FY 2017-18 Results in the month of April 2018.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Neuland Laboratories will announce its FY 2017-18 Results in the month of April 2018.

(Values in Cr.) FY 2017-18 Standalone FY 2017-18 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : We will update the results table above as and when results are announced. Visit again.

Neuland Laboratories Previous Year’s Results (FY 2016-17) :

(Values in Cr.) FY 2016-17 Standalone FY 2016-17 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : If you like this information about Neuland Laboratories Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.